{
    "Trade/Device Name(s)": [
        "GlucoVitaal H1A Blood Glucose Monitoring System",
        "GlucoVitaal H1A Blood Glucose Test Strips",
        "GlucoVitaal H1A Glucose Control Solution"
    ],
    "Submitter Information": "CERAGEM Medisys Inc.",
    "510(k) Number": "K141829",
    "Predicate Device Reference 510(k) Number(s)": [
        "K131727"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JJX"
    ],
    "Summary Letter Date": "September 24, 2014",
    "Summary Letter Received Date": "September 24, 2014",
    "Submission Date": "September 24, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "GlucoVitaal H1A Blood Glucose Test Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometry"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Test Strip",
        "Control Solution",
        "Meter",
        "Lancing device"
    ],
    "Document Summary": "FDA 510(k) summary for GlucoVitaal H1A Blood Glucose Monitoring System for quantitative measurement of glucose in fresh capillary whole blood",
    "Indications for Use Summary": "Intended for self-testing by people with diabetes at home for the quantitative measurement of glucose in fresh capillary whole blood samples from various body sites; not for diagnosis or screening of diabetes or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}